106 results on '"Blacksburg, S.R."'
Search Results
2. Associations between Disclosed Conflicts of Interests and Abstract Prestige at the 2021 ASTRO Annual Meeting
3. Robotic SBRT in Prostate Cancer Patients Younger Than 50 Years Old
4. Stereotactic Body Radiation Therapy for Ultra-Large (> 100 cc) Prostate Glands: Oncologic, Toxicity and Patient-Reported Outcomes
5. Safety and Efficacy of Intracoronary Brachytherapy Protocol for Resistant In-Stent Restenosis
6. The Prognostic Impact of Delayed Time From Biopsy in Men with Low Risk Prostate Cancer Treated with Definitive SBRT
7. Comparisons Between Patients at Suburban and Inner-City Facilities Treated With Prostate SBRT: Long-Term Parity in Outcomes Despite Measurable Differences in Demographic and Disease Profiles
8. Low Body Mass Index As a Risk Factor for Long-Term Proctitis after Prostate SBRT: Assessing the Dosimetric and Clinical Implications
9. Omission of MRI For Treatment Planning Does Not Affect Long-Term Outcomes after Prostate SBRT.
10. Assessing Clinical and Dosimetric Predictors For Low PSA Nadir after Stereotactic Body Radiation Monotherapy with Intraprostatic Dose Escalation
11. Obstructive Uropathy after Prostate SBRT is Rare: Characterizing Clinical and Dosimetric Predictors From a Large Patient Cohort
12. Stereotactic Body Radiation Therapy for Early-Stage Breast Cancer Using a Robotic Linear Accelerator-Longer Term Results from a Multi-Institutional Trial
13. Predictors of Rectal Toxicity in Patients Receiving Prostate SBRT: The Effect of Intrafraction Rotation
14. An Eighteen-Year Longitudinal Analysis of Accepted Prostate Cancer Presentations at the Annual ASTRO Meeting (2000-2017): Historical Trends In SBRT Technique Composition
15. Comparison of 5-Year Outcomes of Stereotactic Body Radiotherapy for African American and white Men Treated for Low Risk Prostate Cancer
16. Assessing the Impact of Increased Dose Rate Output on Bladder and Rectal Quality of Life in Men Treated with Definitive SBRT for Localized Prostate Cancer
17. 5-year Biochemical Outcomes of Stereotactic Body Radiotherapy with Intraprostatic Dose Escalation for Unfavorable Prostate Cancer
18. Prior Transurethral Resection Of The Prostate Does Not Predict For Grade 2+ Urinary Toxicity in Men Receiving Modest Dosing SBRT for Prostate Cancer
19. Positive Family History Does Not Affect Disease Free Survival for Men Treated with SBRT for Localized Prostate Cancer
20. Demographic and Pharmaceutical Predictors of Unfavorable Prostate Cancer
21. Evidence of Stage Migration to Higher Risk Prostate Cancer and its Financial Implications in a Single Institution
22. PSA Nadir 2 Years after Definitive SBRT for Prostate Cancer: Predictors of Absolute PSA Decline
23. Transperineal Gold Marker Implantation Prior to SBRT for Prostate Cancer: A Single Institution Prospective Study to Minimize Patient Discomfort
24. Characterizing Rectal Dosimetry in Patients Who Have Received Definitive SBRT for Prostate Cancer: The 7-year Freedom from Proctitis in a Large Patient Cohort
25. Simulation Order for Patients Undergoing Robotic-based SBRT: Identifying Predictors of Lengthier Insurance Authorization
26. Addressing Billing Errors: Results of a Prospective Quality Assurance Initiative to Optimize the Accuracy of Radiation Oncology Patient Charges
27. Dosimetric Predictors For Attaining Rectal V3600cGy <1cc During SBRT for Prostate Cancer
28. Robotic-Based SBRT for Prostate Cancer is Well Tolerated in Patients with a History of Inflammatory Bowel Disease
29. Grade 2+ Bladder Toxicity in Patients Receiving SBRT for Prostate Cancer: Incidence and Dosimetric Characterization in a Large Patient Cohort
30. Characterizing Intrafraction Target Rotation Correction for Patients Undergoing SBRT for Prostate Cancer
31. Previous Cryotherapy and Older Age Predict for Faster Biochemical Response After Definitive SBRT for Prostate Cancer.
32. Fiducials as Surrogate for Prostate Motion During Robotic SBRT for Prostate Cancer: Predictors of Migration and Interfraction Discursion
33. Stereotactic Body Radiation Therapy for Early-Stage Breast Cancer Using a Robotic Linear Accelerator
34. Chart Rounds at a High Volume Hospital Program: Quantifying Discussion Time as a Function of Patient and Treatment Parameters
35. Testicular Dose as a Function of Robotic Non-coplanar Planimetry: Computing the Effect of Limiting Transtesticular Beam Pathway for Prostate Cancer SBRT
36. Prostate-Specific Antigen Kinetics After Robotic Radiosurgery–Based Stereotactic Body Radiation Therapy (SBRT): The Effect of Pretreatment Clinical Parameters
37. Assessment of Response Following Combination DEB-TACE and SBRT for Unresectable Hepatocellular Carcinoma
38. Quantifying the Emergence of the Stereotactic Era: A Fifteen-Year Analysis of All Accepted ASTRO Presentations 2000-2014
39. Stereotactic Body Radiation Therapy for Early-Stage Breast Cancer Using a Robotic Linear Accelerator
40. Characterizing Radiographic and Pathologic Outcomes After Stereotactic Body Radiation Therapy (SBRT) in the Management of Primary Hepatocellular Carcinoma (HCC)
41. Characterizing the Adoption of Automated, Decision-Based Electronic Checklists in a Busy Academic Practice
42. Combined Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation Therapy (SBRT) for Management of Primary Hepatocellular Carcinoma (HCC)
43. Predicting Long-term Disease State Outcomes in Patients With Prostate Cancer Treated With Definitive Radiation
44. Seminal Vesicle Implantation Does Not Significantly Affect Prostate Cancer Treatment-Related Outcomes
45. Genome-Wide Association Study Identifies a Region on Chromosome 11q14.3 Associated With Late Rectal Bleeding Following Radiation Therapy for Prostate Cancer
46. Improving the Quality and Composition of Electronic Documentation in a Highly Utilized Electronic Medical Record
47. The Potential Impact of Medications on Biochemical Control Following Definitive Management of Prostate Cancer
48. The Relative Effects of Biologically Effective Dose (BED) Versus Adjuvant Androgen Suppression (AS) on Biochemical Control and Post-treatment Biopsy Results Following the Brachytherapy Management of Prostate Cancer
49. Total BED as a Predictor of Rectal Morbidity in Prostate Cancer Treated with Combined EBRT + Brachytherapy versus Brachytherapy Alone
50. Comparison of Long-term Urinary and Sexual Morbidity in Patients with Prostate Cancer Treated with Different Brachytherapy Regimens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.